Patent US5258494A successfully refreshed from Google Patents.
US5258494A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Osteogenic proteins
Assignee: MARIEL THERAPEUTICS Inc
•
Filing: 1992-12-22
•
Granted: 1993-11-02
•
Expires: 2012-12-22
Abstract
Abstract Disclosed are 1) osteogenic devices comprising a matrix containing osteogenic protein and methods of inducing endochondral bone growth in mammals using the devices; 2) amino acid sequence data, amino acid composition, solubility properties, structural features, homologies and various other data characterizing osteogenic proteins, 3) methods of producing osteogenic proteins using recombinant DNA technology, and 4) osteogenically and chondrogenically active synthetic protein constructs.
Inventors
- 👤 Hermann Oppermann
- 👤 Thangavel Kuberasampath
- 👤 David C. Rueger
- 👤 Engin Ozkaynak
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 22:16
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A61K9/0024; A61L; A61L27/00; A61L27/14; A61L27/22; A61L27/227; A61L27/24; A61L27/28; A61L27/34; A61L27/36; A61L27/3604; A61L27/3608; A61L27/3641; A61L27/3645; A61L27/365; A61L27/3654; A61L27/50; A61L27/56; C; C07; C07K; C07K14/00; C07K14/435; C07K14/475; C07K14/51; A61C; A61C8/00; A61C8/0003; A61C8/0004; A61C8/0006; A61F; A61F2310/00; A61F2310/00005; A61F2310/00365; A61K38/00; A61L2430/00; A61L2430/02; A61L2430/06; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/84
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
79 words
A protein, produced by expression of recombinant DNA in a host cell and isolated from said host cell, comprising a pair of polypeptide chains disulfide bonded to form a dimeric species, each of said pair of polypeptide chains having less than 200 amino acids in a sequence sufficiently duplicative of the sequence of: ##STR24## such that said dimeric species has a conformation capable of inducing bone and cartilage formation when implanted in a mammal in association with a matrix.
Claim 2
Dependent Claim
79 words
A protein, produced by expression of recombinant DNA in a host cell and isolated from said host cell, comprising a pair of polypeptide chains disulfide bonded to form a dimeric species, each of said pair of polypeptide chains having less than 200 amino acids in a sequence sufficiently duplicative of the sequence of: ##STR24## such that said dimeric species has a conformation capable of inducing bone and cartilage formation when implanted in a mammal in association with a matrix.
Claim 3
Dependent Claim
27 words
The osteogenic protein of claim 1 having a molecular weight of about 30 kD when oxidized as determined by comparison to molecular weight standards in SDS-polyacrylamide gel.
Claim 4
Dependent Claim
11 words
The osteogenic protein of claim 2 further characterized by being glycosylated.
Claim 5
Dependent Claim
26 words
The osteogenic protein of claim 1 having a molecular weight of about 27 kD as determined by comparison to molecular weight standards in SDS-polyacrylamide gel electrophoresis.
Claim 6
Dependent Claim
12 words
The protein of claim 1 or 4 further characterized by being unglycosylated.
Claim 7
Dependent Claim
19 words
The protein of claim 1 comprising the amino acid sequences: ##STR25## wherein each X independently represents an amino acid.
Claim 8
Dependent Claim
19 words
The protein of claim 1 comprising the amino acid sequences: ##STR26## wherein each X independently represents an amino acid.
Claim 9
Dependent Claim
11 words
The protein of claim 1 comprising the amino acid sequence: ##STR27##
Claim 10
Dependent Claim
11 words
The protein of claim 1 comprising the amino acid sequences: ##STR28##
Claim 11
Dependent Claim
18 words
The protein of claim 1 comprising the product of expression of a DNA in a procaryotic host cell.
Claim 12
Dependent Claim
13 words
The protein of claim 1 produced by expression in a mammalian cell line.
Claim 13
Dependent Claim
22 words
The protein of claim 1 having a half-maximum bone forming activity of at least about 20-25 ng per 25 mg of implant.
Claim 14
Dependent Claim
369 words
The protein of claim 1 comprising the amino acid sequences: ##STR29## wherein X 1 =(K or R); X 2 =(H,R, or K); X 3 =(P, S, E or Q); X 4 =(Y, K or F); X 5 =(D,S or E); X 6 =(R, S, K or A); X 7 =(V, L, or I); X 8 =(N, Q, D or S); X 9 =(D, E or N); X 10 =(I or V); X 11 =(I or V); X 12 =(A or S); X 13 =(P, E, L or K); X 14 =(Y or F); X 15 =(H or D); X 16 =(F, Y or N); X 17 =(H, E or S); X 18 =(E or A); X 19 =(P, A or Q); X 20 =(F or Y); X 21 =(L, M or I); X 22 =(A, P or T); X 22 =(D, E or K); X 24 =(H or S); X 25 =(L, M or F); X 26 =(N or K); X 27 =(S, A or P); X 28 =(T or S); X 29 =(I, V or T); X 30 =(S, A, F or N); X 35 =(V or I); X 36 =(P or S); X 37 =(G or E); X 38 =(K, Q, T or S); X 39 =(I or V); X 40 =(K or E); X 41 =(A, P or S); X 42 =(V or A); X 43 =(T or E); X 44 =(E, Q or K); X 45 =(L or M); X 46 =(S N or D); X 47 =(A, S or P); X 48 =(I, L or V); X 49 =(S or A); X 50 =(M, I or V); X 51 =(Y or F); X 52 =(L, F or Y); X 53 =(D or N); X 54 =(E, D or N); X 55 =(N or Q); X 56 =(E, D, S or K); X 57 =(N or K); X 58 =(V or I); X 59 =(K or R); X 60 =(N, K or H); X 61 =(Q, E, R or P); X 62 =(D, E or N); X 63 =(V or T); X 64 =(E, D or R); X 65 =(G, A, S or E); X 66 =(G or H); and X 67 =(R or H).
Claim 15
Dependent Claim
376 words
The protein of claim 1 comprising the amino acid sequences: ##STR30## wherein X 1 =(Y, K or F); X 2 =(D, S or E); X 3 =(R, S, K or A); X 4 =(V, L, or I); X 5 =(N, Q, D or S); X 6 =(D, E or N); X 7 =(I or V); X 8 =(I or V); X 9 =(A or S); X 10 =(P, E, L or K); X 11 =(Y or F); X 12 =(H or D); X 13 =(F, Y or N); X 14 =(H, E or S); S 15 =(E or A); X 16 =(P, A or Q); X 17 =(F or Y); X 18 =(L, M or I); X 19 =(A, P or T); X 20 =(D, E or K); X 21 =(H or S); X 22 =(L, M or F); X 23 =(N or K); X 24 =(S, A or P); X 25 =(T or S); X 26 =(I, V, or T); X 27 =(V, I or L); X 28 =(T or S); X 29 =(L or I); X 30 = (N, H or R); X 31 =(S, A, F or N); X 32 =(V or I); X 33 =(P or S); X 34 =(G or E); X 35 =(K, Q, T or S); X 36 =(I or V); X 37 =(K or E); X 38 =(A, P or S); X 39 =(V or A); X 40 =(T or E); X 41 =(E, Q or K); X 42 =(L or M); X 43 =(S N or D); X 44 =(A, S or P); X 45 =(I, L or V); X 46 =(S or A); X 47 =(M, I or V); X 48 =(Y or F); X 49 =(L, F or Y); X 50 =(D or N); X 51 =(E, D or N); X 52 =(N or Q); X 53 =(E, D, S or K); X 54 =(N or K); X 55 =(V or I); X 56 =(K or R); X 57 =(N, K or H); X 58 =(Q, E, R or P); X 59 =(D, E or N); X 60 =(V or T); X 61 =(E, D or R); X 62 =(G, A, S or E); X 63 =(G or H); and X 64 =(R or H).
Claim 16
Dependent Claim
21 words
The protein of claim 1 having a half maximum bone-forming activity of at least 20-25 ng per 25 mg of matrix.
Claim 17
Dependent Claim
29 words
An isolated protein comprising a pair of polypeptide chains disulfide bonded to form a dimeric species, at least one of said polypeptide chains comprising the amino acid sequence: ##STR31##
Claim 18
Dependent Claim
29 words
An isolated protein comprising a pair of polypeptide chains disulfide bonded to form a dimeric species, at least one of said polypeptide chains comprising the amino acid sequence: ##STR31##
Claim 19
Dependent Claim
29 words
An isolated protein comprising a pair of polypeptide chains disulfide bonded to form a dimeric species, at least one of said polypeptide chains comprising the amino acid sequence: ##STR32##
Claim 20
Dependent Claim
29 words
An isolated protein comprising a pair of polypeptide chains disulfide bonded to form a dimeric species, at least one of said polypeptide chains comprising the amino acid sequence: ##STR32##
References Cited (Backward Citations)
US4294753A
Cited
US4455256A
Cited
US4394370A
Cited
US4434094A
Cited
EP0128041A2
Cited
EP0148155A2
Cited
US4804744A
Cited
US4563489A
Cited
WO1985005274A1
Cited
WO1986000526A1
Cited
EP0169016A2
Cited
US4843063A
Cited
US4810691A
Cited
US4774322A
Cited
US4563350A
Cited
EP0182483A1
Cited
EP0212474A2
Cited
US5116738A
Cited
US5141905A
Cited
US5187076A
Cited
US5013649A
Cited
US5166058A
Cited
US5106748A
Cited
US5108922A
Cited
WO1988000205A1
Cited
US4877864A
Cited
WO1989009605A1
Cited
WO1989010409A1
Cited
WO1990003733A1
Cited
US5106626A
Cited
WO1990011366A1
Cited
WO1993000049A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-11-01 | 1997-05-03 | 1997-11-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-11-01 | 2001-05-03 | 2001-11-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-11-01 | 2005-05-03 | 2005-11-02 | $7700.00 | Window Closed / Lapsed |